These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 23560033)
1. Salivary microRNAs as promising biomarkers for detection of esophageal cancer. Xie Z; Chen G; Zhang X; Li D; Huang J; Yang C; Zhang P; Qin Y; Duan Y; Gong B; Li Z PLoS One; 2013; 8(4):e57502. PubMed ID: 23560033 [TBL] [Abstract][Full Text] [Related]
2. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma. Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584 [TBL] [Abstract][Full Text] [Related]
3. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Chen Z; Saad R; Jia P; Peng D; Zhu S; Washington MK; Zhao Z; Xu Z; El-Rifai W Cancer; 2013 Jun; 119(11):1985-93. PubMed ID: 23456798 [TBL] [Abstract][Full Text] [Related]
4. A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495 [TBL] [Abstract][Full Text] [Related]
5. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma. Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417 [TBL] [Abstract][Full Text] [Related]
6. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines. Hummel R; Sie C; Watson DI; Wang T; Ansar A; Michael MZ; Van der Hoek M; Haier J; Hussey DJ World J Gastroenterol; 2014 Oct; 20(40):14904-12. PubMed ID: 25356050 [TBL] [Abstract][Full Text] [Related]
8. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study. Duz MB; Karatas OF; Guzel E; Turgut NF; Yilmaz M; Creighton CJ; Ozen M Cell Oncol (Dordr); 2016 Apr; 39(2):187-93. PubMed ID: 26650483 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474 [TBL] [Abstract][Full Text] [Related]
10. Potential miRNA biomarkers for the diagnosis and prognosis of esophageal cancer detected by a novel absolute quantitative RT-qPCR method. Lin Z; Chen Y; Lin Y; Lin H; Li H; Su X; Fang Z; Wang J; Wei Q; Teng J; Zhang Z Sci Rep; 2020 Nov; 10(1):20065. PubMed ID: 33208781 [TBL] [Abstract][Full Text] [Related]
11. A novel serum microRNA signature to screen esophageal squamous cell carcinoma. Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus. Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Svoboda M; Sachlova M; Slaby O Diagn Pathol; 2015 Apr; 10():42. PubMed ID: 25928282 [TBL] [Abstract][Full Text] [Related]
13. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275 [TBL] [Abstract][Full Text] [Related]
15. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening. Xu H; Yao Y; Meng F; Qian X; Jiang X; Li X; Gao Z; Gao L Medicine (Baltimore); 2015 Nov; 94(44):e1558. PubMed ID: 26554762 [TBL] [Abstract][Full Text] [Related]
17. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Xie Z; Yin X; Gong B; Nie W; Wu B; Zhang X; Huang J; Zhang P; Zhou Z; Li Z Cancer Prev Res (Phila); 2015 Feb; 8(2):165-73. PubMed ID: 25538087 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Mathé EA; Nguyen GH; Bowman ED; Zhao Y; Budhu A; Schetter AJ; Braun R; Reimers M; Kumamoto K; Hughes D; Altorki NK; Casson AG; Liu CG; Wang XW; Yanaihara N; Hagiwara N; Dannenberg AJ; Miyashita M; Croce CM; Harris CC Clin Cancer Res; 2009 Oct; 15(19):6192-200. PubMed ID: 19789312 [TBL] [Abstract][Full Text] [Related]
19. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Hu Y; Correa AM; Hoque A; Guan B; Ye F; Huang J; Swisher SG; Wu TT; Ajani JA; Xu XC Int J Cancer; 2011 Jan; 128(1):132-43. PubMed ID: 20309880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]